Apoglyx is a startup based in Germany, most recent round Seed, 1 tracked investor.
Apoglyx is a startup based in Germany. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Apoglyx is a biotech company developing innovative solutions for the treatment of metabolic diseases. Their lead program focuses on a novel therapeutic approach for Type 2 Diabetes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.